Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
$23.87
-2.6%
$23.87
$22.45
$25.44
$2.39MN/A1,194 shs800 shs
LivaNova PLC stock logo
LIVN
LivaNova
$75.86
-0.5%
$79.64
$48.78
$85.76
$4.18B0.86774,484 shs197,120 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
0.00%0.00%0.00%0.00%0.00%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-4.89%-7.68%+8.75%+56.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
$23.87
-2.6%
$23.87
$22.45
$25.44
$2.39MN/A1,194 shs800 shs
LivaNova PLC stock logo
LIVN
LivaNova
$75.86
-0.5%
$79.64
$48.78
$85.76
$4.18B0.86774,484 shs197,120 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
0.00%0.00%0.00%0.00%0.00%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-4.89%-7.68%+8.75%+56.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
0.00
N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
2.73
Moderate Buy$83.5010.08% Upside

Current Analyst Ratings Breakdown

Latest DEMG, CTAG, LIVN, and OPTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Set Price Target$85.00
8/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetBuy$81.00 ➝ $93.00
8/4/2026
LivaNova PLC stock logo
LIVN
LivaNova
Reiterated RatingHold (C)
7/21/2026
LivaNova PLC stock logo
LIVN
LivaNova
UpgradeHoldStrong-Buy
7/15/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetOutperform$90.00 ➝ $95.00
6/30/2026
LivaNova PLC stock logo
LIVN
LivaNova
UpgradeHold
6/22/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetOverweight$83.00 ➝ $92.00
(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
N/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B3.01$4.81 per share15.76$21.98 per share3.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3822.4518.59N/A12.82%16.35%7.76%N/A

Latest DEMG, CTAG, LIVN, and OPTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
$1.385.78%N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21

Institutional Ownership

CompanyInstitutional Ownership
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%

Insider Ownership

CompanyInsider Ownership
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
CompanyEmployeesShares OutstandingFree FloatOptionable
DEMG
Xtrackers FTSE Emerging Comprehensive Factor ETF
N/A100,000N/ANot Optionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable

Recent News About These Companies

LivaNova raises guidance on Q2 beats
LivaNova PLC (LIVN) Q2 2026 Earnings Call Transcript
LivaNova Q2 Earnings Call Highlights
LivaNova (NASDAQ:LIVN) Shares Gap Down - Here's Why
LivaNova: Q2 Earnings Snapshot

Media Sentiment Over Time

LivaNova stock logo

LivaNova NASDAQ:LIVN

$75.86 -0.36 (-0.48%)
As of 01:43 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.